|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
REBEC |
|
Last refreshed on:
|
29 April 2013 |
|
Main ID: |
RBR-2k3kbq |
|
Date of registration:
|
07/03/2012 |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of the effectiveness of the use of pads in adult patients admitted to the Intensive Care Unit
|
|
Scientific title:
|
Comparison of the effectiveness of the use of pads in adult patients with diagnoses of hyperthermia admitted to the Intensive Care Unit |
|
Date of first enrolment:
|
01/03/2012 |
|
Target sample size:
|
27 |
|
Recruitment status: |
not yet recruiting |
|
URL:
|
http://www.ensaiosclinicos.gov.br/rg/RBR-2k3kbq/ |
|
Study type:
|
|
|
Study design:
|
Clinical trial, blind, randomized, controlled, with three arms.
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
Tânia
Chianca |
|
Address:
|
Avenida Alfredo Balena, 190
30130100
Belo Horizonte
Brazil |
|
Telephone:
|
(31)34099887 |
|
Email:
|
taniachianca@gmail.com |
|
Affiliation:
|
Escola de Enfermagem Universidade Federal de Minas Gerais |
|
|
Name:
|
Patrícia
Salgado |
|
Address:
|
Rua Carlos Sá, 641, cs 1
31550200
Belo Horizonte
Brazil |
|
Telephone:
|
(31)87118591 |
|
Email:
|
patriciaoliveirasalgado@gmail.com |
|
Affiliation:
|
Hospital Municipal Odilon Behrens |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: For inclusion of patients in this study will be established the following criteria:
be over 18 years;
body temperature 38.3 ° C;
to consent to participate in the survey or have authorized their participation by signing the Statement of responsibility Consent
Exclusion criteria: Exclusion criteria are:
patient or guardian does not agree to sign the Instrument of Consent;
patients with severe heart disease, traumatic brain injury, malignant hyperthermia, pregnant women, which has a history of adverse reactions following the use of physical methods (hot or cold) in the reduction of body temperature and do not tolerate treatment.
Age minimum:
18
Age maximum:
105
Gender:
-
|
|
Health Condition(s) or Problem(s) studied
|
Fever, infection C23.888.119.344
|
|
Intervention(s)
|
Intervention Group I - Apply warm compress associated with administration of antipyretic. The bandage is soaked in water temperature between 29 and 30 ° C,and remain in the patient for 20 minutes.
Intervention Group II - consisting of patients who apply cold compress associated with administration of antipyretic. The bandage is soaked in ice water, and remain in the patient for 20 minutes.
Control Group - comprised of patients who receive only the administration of antipyretic to reduce body temperature.
The body temperature of patients will be measured at intervals of 30 minutes for 6 hours, according to the time in hours since the change from the point of hypothalamic thermostat setting. Tympanic thermometer will be used to measure body temperature.
|
|
Primary Outcome(s)
|
|
Verify the effectiveness of the use of compress associated with antipyretic for the treatment of adult patients admitted to intensive care unit with a fever. The compresses are applied to the axillary and inguinal regions. The patient's temperature is measured every 10 minutes for a period of 4 hours, this period will also be observed the time that the patient's body temperature took to reach the smaller value 38.3C.
|
|
Secondary Outcome(s)
|
Verify the effectiveness of using a warm compress associated with antipyretic for the treatment of adult patients admitted to intensive care unit with a fever.
The measurements and parameters used to assess this outcome is the same as described for the primary outcome.
|
|
Verify the effectiveness of using cold compress associated with antipyretic for the treatment of adult patients admitted to intensive care unit with a fever. The measurements and parameters used to assess this outcome is the same as described for the primary outcome.
|
|
Secondary ID(s)
|
|
0380.0.203.216-11
|
|
Source(s) of Monetary Support
|
|
Conselho Nacional de Desenvolvimento Científico e Tecnológico - Belo Horizonte, MG, Brazil
|
|